Exelixis Inc

EXEL

NASDAQ

Biotechnology

$51.24

USD

+0.63 (+1.24%)

At close: Aug 14, 2026, 4:00 PM EDT

Market Cap $12.52B

Volume 2.3M

Overview Charts Financials Peers Filings & News Analyst Ratings Technical Analysis

Price Target

$49.00 – $56.00

USD

The 5 analysts offering 1-year price forecasts have a max estimate of $56.00 and a min estimate of $49.00.

Price (USD)

Past 2Y

1Y Forecast

Price Targets

Average Target

$53.20

+$5.2 vs prior

Implied Upside

+3.8%

+10.2% vs prior

Analyst Covering

-2 vs prior period

Consensus

Hold

Improved vs prior

Signal Quality

Consensus Freshness

42%

A mix of recent and older ratings shape this consensus

Analyst Agreement

High

Targets are closely clustered - analysts agree more than usual

Mean vs Median

$0.8000 Gap

Median $54.00 vs avg $53.20 - a few cautious outliers are pulling the average down

Analyst Consensus

Strong Sell

Hold

Strong Buy

Hold

2 Buy

3 Hold

0 Sell

Rating Breakdown

Strong Buy

Buy

Hold

Sell

Strong Sell

5 analysts · last 3 months

Covering Analysts

Unlock each analyst's profile, success rate + price targets

Free shows the consensus and each analyst's current rating.

Analyst	Firm	Rating	Action	Date	Success Rate	Price Target	Implied Upside
Etzer Darout	BMO Capital	Hold	Maintained	4 weeks ago	Plus	Plus	Plus
Robert Burns	HC Wainwright & Co.	Buy	Reiterated	1 month ago	Plus	Plus	Plus
Ashwani Verma	UBS	Hold	Maintained	1 month ago	Plus	Plus	Plus
Gregory Renza	Truist Securities	Hold	Downgraded	1 month ago	Plus	Plus	Plus
Silvan Turkcan	JMP Securities	Buy	Maintained	1 month ago	Plus	Plus	Plus